ArrowMark Colorado Holdings LLC 13D and 13G filings for C4 Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2023-06-12 4:13 pm Sale | 2023-05-31 | 13G | C4 Therapeutics, Inc. CCCC | ArrowMark Colorado Holdings LLC | 1,493,450 3.040% | -4,309,421 (-74.26%) | Filing |
| 2023-02-14 5:30 pm Purchase | 2022-12-31 | 13G | C4 Therapeutics, Inc. CCCC | ArrowMark Colorado Holdings LLC | 5,802,871 11.850% | 389,143 (+7.19%) | Filing |
| 2022-06-10 08:44 am Purchase | 2022-05-31 | 13G | C4 Therapeutics, Inc. CCCC | ArrowMark Colorado Holdings LLC | 5,413,728 11.090% | 5,413,728 (New Position) | Filing |